BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35364211)

  • 1. Adjuvant radiation following clear margin resection of high T-stage cutaneous squamous cell carcinoma halves the risk of local and locoregional recurrence: A dual-center retrospective study.
    Ruiz ES; Kus KJB; Smile TD; Murad F; Zhou G; Ilori EO; Schoenfeld JD; Margalit DN; Tishler RB; Vidimos AT; Koyfman SA; Schmults CD
    J Am Acad Dermatol; 2022 Jul; 87(1):87-94. PubMed ID: 35364211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the utility of localized adjuvant radiation for node-negative primary cutaneous squamous cell carcinoma with clear histologic margins.
    Ruiz ES; Koyfman SA; Que SKT; Kass J; Schmults CD
    J Am Acad Dermatol; 2020 Feb; 82(2):420-429. PubMed ID: 31349042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of Adjuvant Radiotherapy Following Negative Surgical Margins for Cutaneous Squamous Cell Carcinoma.
    Miller J; Chang T; Schwartz D; Peters M; Baum C
    Dermatol Surg; 2019 Sep; 45(9):1111-1116. PubMed ID: 30893176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes in intermediate-risk squamous cell carcinomas treated with Mohs micrographic surgery compared with wide local excision.
    Xiong DD; Beal BT; Varra V; Rodriguez M; Cundall H; Woody NM; Vidimos AT; Koyfman SA; Knackstedt TJ
    J Am Acad Dermatol; 2020 May; 82(5):1195-1204. PubMed ID: 31887322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the 2022 National Comprehensive Cancer Network Risk Stratification for Cutaneous Squamous Cell Carcinoma.
    Stevens JS; Murad F; Smile TD; O'Connor DM; Ilori E; Koyfman S; Vidimos A; Waldman AB; Ruiz ES
    JAMA Dermatol; 2023 Jul; 159(7):728-735. PubMed ID: 37285135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant radiotherapy may not significantly change outcomes in high-risk cutaneous squamous cell carcinomas with clear surgical margins: A systematic review and meta-analysis.
    Kim Y; Lehrer EJ; Wirth PJ; Khesroh EA; Brewer JD; Billingsley EM; Zaorsky NG; Lam C
    J Am Acad Dermatol; 2022 Jun; 86(6):1246-1257. PubMed ID: 34890701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term clinical outcomes of patients with invasive cutaneous squamous cell carcinoma treated with Mohs micrographic surgery: A 5-year, multicenter, prospective cohort study.
    Tschetter AJ; Campoli MR; Zitelli JA; Brodland DG
    J Am Acad Dermatol; 2020 Jan; 82(1):139-148. PubMed ID: 31279037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of American Joint Committee on Cancer, International Union Against Cancer, and Brigham and Women's Hospital tumor staging for cutaneous squamous cell carcinoma.
    Karia PS; Jambusaria-Pahlajani A; Harrington DP; Murphy GF; Qureshi AA; Schmults CD
    J Clin Oncol; 2014 Feb; 32(4):327-34. PubMed ID: 24366933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of Patients With Multiple Cutaneous Squamous Cell Carcinomas: A 10-Year Single-Institution Cohort Study.
    Levine DE; Karia PS; Schmults CD
    JAMA Dermatol; 2015 Nov; 151(11):1220-5. PubMed ID: 26177278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Narrow excision margins are appropriate for Merkel cell carcinoma when combined with adjuvant radiation: Analysis of 188 cases of localized disease and proposed management algorithm.
    Tarabadkar ES; Fu T; Lachance K; Hippe DS; Pulliam T; Thomas H; Li JY; Lewis CW; Doolittle-Amieva C; Byrd DR; Kampp JT; Parvathaneni U; Nghiem P
    J Am Acad Dermatol; 2021 Feb; 84(2):340-347. PubMed ID: 32711093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indications for adjuvant radiotherapy in high-risk cutaneous squamous cell carcinoma with clear margins: a Delphi consensus.
    Moscarella E; Di Brizzi EV; Alpi P; Arcelli A; Badellino S; Bossi P; Calzavara-Pinton PG; Di Stefani A; Dika E; Eibenschutz L; Fargnoli MC; Fionda B; Gravina GL; Leonulli BG; Longo C; Lospalluti L; Nardone V; Pimpinelli N; Quaglino P; Queirolo P; Rubegni P; Tagliaferri L; Troiani T; Vavassori A; Argenziano G
    Br J Dermatol; 2024 Mar; 190(4):578-579. PubMed ID: 38092023
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical outcomes of high-risk cutaneous squamous cell carcinomas treated with Mohs surgery alone: An analysis of local recurrence, regional nodal metastases, progression-free survival, and disease-specific death.
    Soleymani T; Brodland DG; Arzeno J; Sharon DJ; Zitelli JA
    J Am Acad Dermatol; 2023 Jan; 88(1):109-117. PubMed ID: 35760236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher metastasis and death rates in cutaneous squamous cell carcinomas with lymphovascular invasion.
    Kus KJB; Murad F; Smile TD; Chang M; Ashrafzadeh S; Zhou G; Ilori EO; Koyfman SA; Vidimos AT; Schmults CD; Ruiz ES
    J Am Acad Dermatol; 2022 Apr; 86(4):766-773. PubMed ID: 34774657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanomas of the head and neck have high-local recurrence risk features and require tissue-rearranging reconstruction more commonly than basal cell carcinoma and squamous cell carcinoma: A comparison of indications for microscopic margin control prior to reconstruction in 13,664 tumors.
    Fix W; Etzkorn JR; Shin TM; Howe N; Bhatt M; Sobanko JF; Miller CJ
    J Am Acad Dermatol; 2021 Aug; 85(2):409-418. PubMed ID: 30458206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of prognostic prediction ability of the novel Japanese risk factor scoring system in a Japanese cohort of resectable cutaneous squamous cell carcinoma: A retrospective cross-sectional study.
    Doi R; Baba N; Kato H; Nakamura M; Matsushita S; Aoki M; Fujimoto N; Kato T; Iino S; Saito S; Yasuda M; Asai J; Ishikawa M; Yatsushiro H; Kawahara Y; Inafuku K; Matsuya T; Araki R; Teramoto Y; Hasegawa M; Nakama T; Nakamura Y
    Exp Dermatol; 2023 Oct; 32(10):1682-1693. PubMed ID: 37395158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total Margin Control Is Superior to Traditional Margin Assessment for Treatment of Low-Stage Penile Squamous Cell Carcinoma.
    O'Connell KA; Thomas JL; Murad F; Zhou G; Sonpavde GP; Mossanen M; Clinton TN; Ji-Xu A; Alton K; Spiess PE; Rossi AM; Schmults CD
    J Urol; 2024 Jan; 211(1):90-100. PubMed ID: 37788015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival.
    Brandwein-Gensler M; Teixeira MS; Lewis CM; Lee B; Rolnitzky L; Hille JJ; Genden E; Urken ML; Wang BY
    Am J Surg Pathol; 2005 Feb; 29(2):167-78. PubMed ID: 15644773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage of Recurrence after Surgery and Adjuvant Therapy: A Multi-institutional Study.
    Zenga J; Graboyes E; Janz T; Drake V; Rettig E; Desai S; Nickel C; Shabani S; Padhya T; Scarpinato M; Stadler M; Massey B; Campbell B; Shukla M; Awan M; Schultz CJ; Wong S; Jackson RS; Pipkorn P
    Otolaryngol Head Neck Surg; 2019 Jul; 161(1):74-81. PubMed ID: 30753110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune status does not independently influence cutaneous squamous cell carcinoma metastasis and death when stratified by tumor stage: A dual-center retrospective cohort analysis of primary N0 disease.
    O'Connor DM; Murad F; Danesh MJ; Butler W; Smile TD; Ilori EO; Gastman BR; Vidimos A; Waldman AB; Schmults CD; Koyfman S; Ruiz ES
    J Am Acad Dermatol; 2022 Dec; 87(6):1295-1302. PubMed ID: 36063987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Margin status revisited in vulvar squamous cell carcinoma.
    Te Grootenhuis NC; Pouwer AW; de Bock GH; Hollema H; Bulten J; van der Zee AGJ; de Hullu JA; Oonk MHM
    Gynecol Oncol; 2019 Aug; 154(2):266-275. PubMed ID: 31109660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.